Objective: The purpose of this scoping review was to systematically identify and describe
literature that uses a health equity–oriented approach for preventing and reducing the harms …

Purpose Hepatocellular carcinoma (HCC) is most often a sequela of chronic liver disease or
chronic hepatitis B infection. Among high-risk patients, surveillance for HCC every 6 months …

Purpose Hepatocellular carcinoma has a dismal prognosis, except in patients diagnosed
early who are candidates for potentially curative therapies. Most HCC cases develop in …

Harm reduction (HR) approaches to substance use show promising efficacy, but limited
research exists exploring professional counselors' perceptions of HR. An online survey …

Background: Supervised consumption sites (SCS) are an evidence-based intervention
proven effective for preventing drug overdose deaths. Obstacles to accessing SCS include …

Background Cannabis use can generate potential avoidable harms, hence the need for
effective preventive measures and treatment. Studies show the efficacy of harm reduction …

Abstract Background In Australia, only 22% of people with chronic hepatitis B (CHB) are
clinically managed; and a national effort is engaging primary care workforce in providing …

Background and objectives In Australia, mortality rates for hepatocellular carcinoma (HCC)
are rising. Targeted surveillance is recommended to increase early diagnosis. The aim of …

Background: About 13.3% of the South African population use some kind of substance
during their lifetime. The incidence of substance use disorders is twice the global average …

Aims: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer.
While patients who are known to be at high risk for HCC should be under surveillance, only …